SciELO - Scientific Electronic Library Online

vol.60 issue3Design of an allele-specific PCR assay to genotype the rs12255372 SNP in a pilot study of association between common TCF7L2 polymorphisms and type 2 diabetes in VenezuelansGender differences in insulin and C-peptide concentrations at birth using cord blood collection author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



  • text new page (beta)
  • English (pdf)
  • Article in xml format
  • How to cite this article
  • SciELO Analytics
  • Curriculum ScienTI
  • Automatic translation


Related links


Archives of Endocrinology and Metabolism

Print version ISSN 2359-3997On-line version ISSN 2359-4292

Arch. Endocrinol. Metab. vol.60 no.3 São Paulo June 2016 


Calcium intake: good for the bones but bad for the heart? An analysis of clinical studies

Guilherme Alcantara Cunha Lima1  2 

Priscilla Damião Araújo Lima2  3 

Maria da Glória Costa Reis Monteiro de Barros3  4 

Lívia Paiva Vardiero3 

Elisa Fernandes de Melo3 

Francisco de Paula Paranhos-Neto1 

Miguel Madeira1  5 

Maria Lucia Fleiuss de Farias1 

1 Serviço de Endocrinologia da Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil

2 Serviço de Clínica Médica da Faculdade de Medicina de Campos (FMC), Campos dos Goytacazes, RJ, Brasil

3 Serviço de Reumatologia da Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil

4 Serviço de Clínica Médica do Centro Universitário Serra dos Órgãos (Unifeso), Teresópolis, RJ, Brasil

5 Serviço de Clínica Médica da Universidade do Grande Rio (Unigranrio), Rio de Janeiro, RJ, Brasil


The proper dietary calcium intake and calcium supplementation, when indicated, are important factors in the acquisition of peak bone mass during youth and in the prevention of fractures in old age. In addition to its deposition in bone, calcium confers an increase in its resistance and exhibits important activities in different enzymatic pathways in the body (e.g., neural, hormonal, muscle-related and blood clotting pathways). Thus, calcium supplementation can directly or indirectly affect important functions in the body, such as the control of blood pressure, plasma glucose, body weight, lipid profile and endothelial function. Since one publication reported increased cardiovascular risk due to calcium supplementation, many researchers have studied whether this risk actually exists; the results are conflicting, and the involved mechanisms are uncertain. However, studies that have evaluated the influence of the consumption of foods rich in calcium have reported no increase in the cardiovascular risk, which suggests that nutritional intake should be prioritized as a method for supplementation and that the use of calcium supplements should be reserved for patients who truly need supplementation and are unable to achieve the recommended daily nutritional intake of calcium.

Key words: Calcium supplementation; dietary calcium; osteoporosis; cardiovascular safety; cardiovascular mortality


Calcium plays an important role in the human body. Calcium mediates nervous excitability, muscle contractility, hormone secretion and blood clotting. Bones are the major calcium reservoir in the human body and holding 99% of the total bodily calcium. Calcium storage in the form of hydroxyapatite crystals provides rigidity to bones and minimizes the risk of fractures (1). Calcium is known to play important roles in the prevention and treatment of osteoporosis (2). However, the close relationships of calcium with myocardial contraction, nerve conduction, hormonal modulation and blood clotting may result in increased cardiovascular risk (3) (Figure 1).

In addition to confer resistance to bones and teeth, calcium plays an important role in several regulatory pathways in the body. It acts by modifying the activity of cellular receptors, in signal transduction and as a cofactor in various enzyme systems, thus modulating the secretion of hormones, such as insulin, mediating contractility of striated and smooth muscle, neuronal transmission and cardiac conduction besides being required in the intrinsic, extrinsic and common pathways of the coagulation system. The maintenance of serum calcium levels is required for the proper functioning of organism.

Figure 1 Calcium functions in the body. 

Indeed, patients with hypercalcemia exhibit increased mortality due to cardiac and vascular complications (4-6). Recent studies have evaluated the effects of medicinal calcium supplementation on cardiovascular risk and produced conflicting results (6-24) that have led to concerns about the safety of calcium supplementation and its role in the treatment of osteoporosis (25).

Studies that have evaluated the intake of calcium food sources have reported neutral or protective effects on major cardiovascular outcomes, such as atherosclerosis (26-28), blood pressure (29), diabetes (30,31) and body weight (32) and the risks of infarction (15,24), stroke (21,23,24) and cardiovascular mortality (6,7,24). Moreover, such food sources result in the minimization of the risk of nephrolithiasis (33), which is known to be increased by medicinal calcium supplementation (34), and these food sources can provide other nutrients, such as proteins, which are useful in maintaining bone mass in adults (35,36) and can minimize the risks of malnutrition and sarcopenia, which are indirectly related to bone quality and the risk of fractures (37). Thus, calcium intake from dietary sources should be a priority, and supplements should be reserved for patients who are at a real risk of osteoporotic fractures and who cannot achieve their daily nutritional needs. Drug overdoses must be avoided because transient hypercalcemia might be associated with increased cardiovascular risk (25,35,38).

The current review aims to analyze the importance of calcium in bone integrity and to discuss the main studies that have evaluated the cardiovascular safety of calcium supplementation.


During the periodo between 07/15/2015 and 09/18/2015, we reviewed all studies published from 1990 and 2015 on this subject in the PubMed and Capes portal databases. The following terms were searched: calcium supplementation and bone health, calcium supplementation and fractures, calcium supplementation and mortality, calcium supplementation and cardiovascular risk, calcium supplementation and hypertension, calcium supplementation and diabetes, calcium supplementation and obesity, and calcium supplementation and nephrolithiasis. Only studies published in English were considered. Among all of the pre-selected publications, we prioritized systematic reviews, meta-analyses, randomized controlled trials (RCT), longitudinal studies and recent publications.

Calcium and bone health

Osteoporosis is characterized by decreased bone mass and microarchitectural deterioration that results in an increased risk of fracture (39). Although this disease is primarily diagnosed in the elderly, osteoporosis prevention should begin in childhood and adolescence via the adoption of behaviors that are aimed at the proper acquisition of peak bone mass and the prevention of bone mass loss, such as engaging in physical activity, refraining from smoking and consuming alcohol, increasing sun exposure, and the consumption of calcium-rich foods (40).

Studies that have evaluated the influences of eating foods rich in calcium during childhood and adolescence on bone health have been conducted. A recent double-blind RCT evaluated 220 teens after two years of low, medium or high calcium intake levels (through fortified milk) and found an increase in the bone mass of the female adolescents who ingested more calcium (41). Women who drink less milk during childhood and adolescence exhibit lower bone mass and an increased risk of fracture as adults (42).

The intake of calcium and its correlations with bone mineral density (BMD) and fractures in adults have also been assessed. Recently, Kim and cols. (43) evaluated 7,260 men and women aged ≥ 50 years and found that calcium intakes < 400 mg/day were correlated with lower BMD in the lumbar spine, lower femoral cortical thicknesses (in both genders) and lower BMD in the femoral neck (only in women). In contrast, intakes greater than 1,200 mg/day were positively correlated with BMD in the lumbar spine and femoral neck (only in men). Elderly people with higher milk or milk and yogurt intakes at baseline have been found to be a lower risk of hip fractures when assessed 10 years later (44). A reduced risk of fractures (30%) in subjects with higher nutritional calcium intakes was also recently described by Khan and cols. (24). Moreover, Key and cols. (45) reported an increased fracture risk in women with daily calcium intakes below 525 mg/day.

The effectiveness of isolated calcium supplementation in the prevention of osteoporotic fractures remains controversial. A meta-analysis involving 170,991 women and 68,606 men found that isolated calcium intake was not associated with a reduced fracture risk (46). Shea and cols. (47) evaluated the results from 1,806 participants and found that despite a BMD increase, isolated calcium supplementation did not reduce the risk of non-vertebral fractures. Similarly, the RECORD study evaluated the efficacies of supplementations with calcium, vitamin D or both in the elderly in the secondary prevention of low-impact fractures and concluded that none of these methods was effective in reducing the risk (48). However, Tang and cols. (49) published a meta-analysis that included 29 RCT and concluded that combined supplementation resulted in a reduction in the risk of fractures in patients aged 50 years or more. Another study reported a reduced risk of osteoporotic fractures and improvements in parameters related to bone density in women who consumed more than 80% of their calcium supplements per year over five years, which suggests that adherence to treatment is critical for the effectiveness of therapy (50). Low patient compliance with supplementation regimens due either to poor treatment adherence or gastrointestinal symptoms associated with calcium supplements may be one of the important determinants of these conflicting results (18,47-49).

Another factor that should be considered is that the intake of foods rich in calcium is not sufficient to meet the recommended dietary allowance (RDA) for most of the population. A chronic negative calcium balance may result in the stimulation of bone demineralization and negatively influence treatment efficacy. Heaney and cols. (51) reanalyzed six large studies and found that the calcium intakes of 85% of the participants were below the RDA. In our country, Pinheiro and cols. (52) reported the same problem and emphasized that the participants consumed only one-third of the daily calcium recommendation on average.

Combined calcium and vitamin D supplementation is classically recommended for the treatment of osteoporosis. Vitamin D deficiency may adversely affect bone mass by promoting reduced gastrointestinal calcium absorption and potentially promoting the hypersecretion of PTH, which stimulates bone resorption to restore the ionized calcium levels in the extracellular fluid (53). The ability to increase intestinal calcium absorption protects both youth and adults from bone demineralization. However, this ability becomes restricted in elderly people who need to use their body calcium to maintain homeostasis, which increases their risk of osteoporosis (40,54). Additionally, elderly individuals have lower levels of 7-dehydrocholesterol in their skin and are therefore less able to synthesize vitamin D from sun exposure, which may aggravate calcium imbalances and result in secondary hyperparathyroidism (55). Thus, inadequate vitamin D status can exacerbate the detrimental effects of low calcium intake, and vitamin D is therefore essential for the intestinal absorption of this ion at a level that is adequate to enable bone remodeling (35).

Kim and cols. (43) only observed a correlation between low calcium intake and reduced BMD in a subgroup with concomitant vitamin D deficiency, which reinforces the importance of vitamin D in conferring the benefits of calcium to the bones. Additionally, vitamin D supplementation leads to improved muscle strength, especially in the elderly (56), and reduces the risk of falls, which constitutes an additional factor in the prevention of osteoporotic fractures (57). Indeed, studies that have analyzed combined supplementation have observed the preservation of BMD, reductions of serum PTH and bone resorption markers (58), and reductions in the risk of fractures (2,49,59).

Calcium and vitamin D supplementation should not be generalized applied because individuals with low fracture risks need to be considered. Studies that have evaluated the effectiveness of indiscriminate treatment with calcium and vitamin D have failed to observe benefits regarding the risk of fractures because the individuals included in these studies exhibited very low risks of fractures and thus did not benefit from supplementation (34). Accordingly, the authors of a Cochrane review found that despite small increases in the BMD of healthy children, calcium supplementation was not able to reduce the risk of fractures, and these authors concluded that routine supplementation should not be recommended (60). Verbrugge and cols. (25) advocated calcium and vitamin D supplementation only for patients with documented risks of fractures, such as elderly patients, institutionalized patients, patients with diagnoses of osteoporosis and chronic glucocorticoid users. Furthermore, excessive supplementation above the RDA (Table 1) (61) should be avoided because it increases the risk of adverse effects and confers no additional benefit (25,35).

Table 1 Daily recommended calcium intake (Source: International Osteoporosis Foundation 2014 – Ref. 61) 

Age/Gender Calcium (mg/day)
0-6 months old 200
6-12 months old 260
1-3 years old 700
4-8 years old 1,000
9-18 years old 1,300
Pregnancy/lactation (14-18 years old) 1,300
19-50 years old 1,000
Pregnancy/lactation (19-50 years old) 1,000
Postmenopausal or ≥ 51 years old 1,200
19-70 years old 1,000
≥ 71 years old 1,200

Calcium and cardiovascular risk

Given the frequent use of calcium supplementation for the prevention and treatment of osteoporosis in many patients, the safety profile of calcium supplementation and its potential interactions with other metabolic pathways that are related to the cardiovascular system have been tested in several studies (6-24) (Tables 2 and 3). Major concerns have been expressed following reports in some studies of increased cardiovascular risks associated with calcium supplementation (10-12,15,19).

Bolland and cols. (9) evaluated 1,471 postmenopausal women over 5 years and observed trends toward increased risks of myocardial infarction (MI) and stroke in the group that received calcium citrate. It is worth emphasizing that calcium supplementation was not administered with vitamin D in this study. The studied groups received high calcium doses (1,000 mg/day) that exceeded the RDA when the subjects’ average dietary calcium intakes were included (860 mg/day; Table 1). The same group of researchers then performed a meta-analysis of 16 studies that evaluated the cardiovascular outcomes of patients who received ≥ 500 mg/day of calcium and observed an increased risk of MI (31%); however, the risks of although stroke, sudden death, and MI + stroke + sudden death did not differ between the groups (11). This meta-analysis only evaluated studies with isolated calcium supplementation, which has resulted in criticisms of the design of this study. Bolland and cols. (12) subsequently published a new meta-analysis of 12 RCT (29,277 participants) that included the randomly selected subgroup of the WHI study that did not take calcium supplements and concluded that combined calcium and vitamin D supplementation increased the risks of MI and MI + stroke.

Other important studies have also reported increased MI risks in adult men and women (15) and an increased risk of death due to cardiovascular diseases in men (10,19) (Table 2). It is important to highlight that most of these studies were not designed to evaluate cardiovascular risk as a primary endpoint. The primary outcomes of these studies were the effects of calcium and/or vitamin D supplementation on fracture risk and not cardiovascular risk. Furthermore, the lack of standard criteria for the diagnosis of cardiovascular complications may have resulted in the under- or overestimation of the actual prevalences of these complications and thus resulted in possible bias in the results (25).

Table 2 Relationships between calcium supplementation and cardiovascular outcomes 

Authors Year Number of participants Characteristics of participants Study design Results
Bostick and cols. (7) 1999 34,486 55-69 years Post-menopausal women without previous ischemic heart disease (IHD) Prospective cohort study Follow-up 8 years No correlation between calcium supplementation and IHD death
Hsia and cols. (8) 2007 36,282 50-79 years Post-menopausal women WHI participants Prospective RCT study Follow-up 7 years No correlation between calcium/vitamin D supplementation and MI/stroke
Bolland and cols. (9) 2008 1,471 Post-menopausal women Prospective RCT study Follow-up 5 years Positive trends between calcium supplementation and MI/stroke
Pentti and cols. (10) 2009 10,555 52-62 years Women without CHD at baseline Prospective cohort study Follow-up 7 years Positive correlation between calcium/vitamin D supplementation and CHD (24%)
Bolland and cols. (11) 2010 20,072 Double-bind RCT studies > 40 years Calcium supplements Meta-analysis (15 RCT studies) Positive correlation between calcium supplementation and MI (27%) No correlation between calcium supplementation and stroke/sudden death/ MI + stroke + sudden death
Bolland and cols. (12) 2011 28,072 RCT studies Calcium or calcium/vitamin D supplements Meta-analysis (9 RCT studies) Positive correlation between calcium/vitamin D supplementation and MI (24%)/MI + stroke (15%)
Lewis and cols. (13) 2011 1,460 75 ± 2.7 years Women with preexisting atherosclerotic vascular disease Prospective double-bind RCT study Follow-up 4,5 years No correlation between calcium supplementation and atherosclerosis/general mortality
Avenell and cols. (14) 2012 5,292 ≥ 70 years (women: 85%) Previous osteoporotic fracture Prospective RCT study Follow-up 24-68 months No correlation between calcium calcium/vitamin D supplementation and general mortality No correlation between calcium or calcium/vitamin D supplementation and vascular disease mortality
Li and cols. (15) 2012 23,980 35-64 years (women: 54%) Without major CVD events Prospective cohort study Follow-up 11 years Positive correlation between calcium supplementation and MI (86%) No correlation between calcium supplementation and stroke/general mortality
Rejnmark and cols. (16) 2012 70,528 Vitamin D or calcium/vitamin D supplements Women (86,8%) Median age: 70 years Meta-analysis (8 RCT studies) Negative correlation between calcium supplementation and general mortality (9%)
Langsetmo and cols. (17) 2013 9,033 ≥ 25 years (women: 69.6%) Non-missing Calcium/Vitamin D intakes Prospective cohort study Follow-up 10 years Negative correlation between calcium supplementation + dietary calcium and general mortality (22%), independently of vitamin D intake
Prentice and cols. (18) 2013 46,892 50-79 years Post-menopausal women WHI participants Prospective RCT study Follow-up 7 years No correlation between calcium/vitamin D supplementation and MI/stroke/CVD death/general mortality
Van Hemelrijck and cols. (6) 2013 20,024 ≥ 17 years (women: 52,5%) without history of heart disease NHANES III participants Prospective cohort study No correlation between calcium supplementation and CVD death
Xiao and cols. (19) 2013 388,229 50-71 years (Women: 43,5%) NIH participants Prospective cohort study Follow-up 12 years Positive correlation between calcium supplementation and CVD death in men (20%) No correlation between calcium supplementation and stroke in women No correlation between calcium supplementation and CVD death/stroke in women
Paik and cols. (20) 2014 74,285 30-55 years Women without history of CVD or cancer Prospective cohort study Follow-up 24 years Negative correlation between calcium supplementation + CVD (18%)/MI (29%) in women No correlation between calcium supplementation and stroke

RCT: randomized placebo-controlled trial.

In contrast, other studies have failed to find an association between calcium supplementation and the risk of cardiovascular complications (6-8,13,14,16-18,20) (Table 2). The initial assessments of the WHI participants revealed that medicinal calcium supplementation did not increase the risks of MI or stroke even in the subgroup with higher dietary calcium intake (8). However, separate subgroup analyses were not performed in this study; thus, individuals who did and did not use calcium supplements at the time of randomization were analyzed together, contrary to Bolland and cols. analysis (12), that includes only WHI patients who had no previous use of calcium supplements.

The WHI study participant data were re-evaluated after the publication of the study by Bolland and cols. (12) with a focus on whether the women participants were or were not using calcium supplements at the time of WHI enrollment, and no associations of calcium supplementation with increased risks of MI, stroke, coronary heart disease or death were observed in any of the subgroups (18). In an analysis of 20,024 National Health and Nutrition Examination Survey III (NHANES III) participants, no increase in cardiovascular diseases (CVD) mortality secondary to dietary or medicinal calcium intake was observed, although the risk of death from CVD was higher among patients with underlying hypercalcemia (6). A meta-analysis involving 8 RCT encompassing 70,528 participants with a mean age of 70 years concluded that calcium/vitamin D supplementation was associated with a 9% reduction in the risk of death from all causes (16). A recently published study analyzed 74,245 women over 24 years and found that calcium supplementation exhibited protective effects against cardiovascular and coronary heart diseases (CHD) and a neutral effect on stroke (20).

The influence of dietary calcium intake on cardiovascular outcomes has also been evaluated (6,7,15,17,19,21-24) (Table 3). A subgroup that ingested > 1,425 mg/day of calcium on average exhibited a reduction in the risk of CVD mortality of 33% compared with a subgroup with a calcium intake < 696 mg/day (7). Negative correlations of dietary calcium intake with MI (15,24) and stroke (21,23,24) risks have also described. Levitan and cols. (23) assessed the subgroup of WHI participants who were hospitalized due to heart failure over a period of 4.6 years (3,340 patients) and concluded that dietary calcium intake was not correlated with the risk of death. In a recent publication, Khan and cols. (24) demonstrated that the group with the highest dietary calcium intake (median of 1,348 mg/day) presented good cardiovascular safety profiles (a 14% reduction in mortality from all causes, a 16% reduction in non-fatal CVD and a 31% reduction in stroke) compared with the group with the lowest dietary calcium intake (median of 473 mg/day).

Table 3 Relationships between dietary calcium and cardiovascular outcomes 

Authors Year Number of participants Characteristics of participants Study design Results
Bostick and cols. (7) 1999 34,486 55-69 years Women post-menopausal without previous IHD Prospective cohort study Follow-up 8 years Negative correlation between dietary calcium and CVD death (37%)
Iso and cols. (21) 1999 85,764 34-59 years Women NHS participants Prospective cohort study Follow-up 14 years Negative correlation between dietary calcium and stroke (31%) in women
Li and cols. (15) 2012 23,980 35-64 years (women: 54%) without major CVD events Prospective cohort study Follow-up 11 years Negative correlation between dietary calcium and MI (31%) No correlation between dietary calcium and stroke/CVD death
Langsetmo and cols. (17) 2013 9,033 ≥ 25 years (Women: 69,6%) Non-missing CaVit D intakes Prospective cohort study Follow-up 10 years Trends to negative correlation between dietary calcium and general mortality
Larsson and cols. (22) 2013 9,095 History of stroke Meta-analysis (11 RCT studies) Negative correlation between dietary calcium and stroke (22%)
Levitan and cols. (23) 2013 3,340 50-79 years Post-menopausal women WHI participants Heart failure hospitalization Prospective cohort study Follow-up 4-6 years No correlation between dietary calcium and CVD death
Van Hemelrijck and cols. (6) 2013 20,024 ≥ 17 years (women: 52,5%) without history of heart disease NHANES III participants Prospective cohort study No correlation between dietary calcium and CVD death
Xiao and cols. (19) 2013 388,229 50-71 years (Women: 43,5%) NIH participants Prospective cohort study Follow-up 12 years No correlation between dietary calcium and CVD death/stroke
Khan and cols. (24) 2015 34,468 40-69 years (women: 60,3%) Without CVD, cancer and diabetes previous Prospective cohort study Follow-up 12 ± 1,5 years Negative correlation between dietary calcium and all-cause mortality (14%)/non-fatal CVD (16%)/stroke (31%)

Calcium and cardiovascular risk: assumptions

The relationship between calcium supplementation and CVD risk and the manners in which calcium might protect or damage the cardiovascular system (62) remain inconclusive. The main hypothesis is that the sudden elevation of serum calcium levels after supplementation may result in increased vascular resistance and calcification as well as cardiac arrhythmias (3,9). Increased serum calcium levels have been observed 60-90 minutes after medicinal supplementation (63). However, Burt and cols. (64) evaluated endothelial function and myocardial perfusion parameters before and 3 hours after supplementation with 1,000 mg of calcium citrate and concluded that despite the elevated calcium levels, arterial constriction decreased, and myocardial perfusion increased; these results are suggestive of the cardioprotective effects of calcium. Slinin and cols. (4) reported a higher incidence of cardiovascular events among patients with hypercalcemia but failed to demonstrate that calcium intake was associated with increased baseline calcium levels in these patients.

Vitamin D insufficiency/deficiency is another possibility because it is highly prevalent among the elderly (i.e., the group with the greatest need for calcium supplementation) and has been consistently related to increased cardiovascular risk (65). Most studies have not assessed the levels of 25-OH vitamin D at baseline and after supplementation, which hinders their interpretations. However, because vitamin D insufficiency/deficiency is a highly prevalent disorder in several regions of the world across different age groups and socioeconomic classes (66), it is unlikely that a higher incidence of vitamin D deficiency in the intervention group compared with the placebo could account for this difference in cardiovascular risk (16).

Calcium supplementation does not seem to influence the emergence or worsening of hyperparathyroidism, which is a condition that is also associated with cardiovascular risk. A recent study found that calcium supplementation reduced the number of new cases of primary hyperparathyroidism among women (67). Another study found that calcium and vitamin D supplementation for 8 weeks reduced PTH serum levels by 17% (68). Calcium supplementation in patients with primary HPT resulted in reduced serum PTH levels in 17 of the 24 studied cases (69).

Calcium and endothelial function

Despite the higher prevalence of atherosclerotic plaques in the carotid arteries of patients with higher serum calcium levels (70), Lewis and cols. (71) found no increases in the risk of atherosclerotic plaques or carotid intima-media thicknesses in elderly women who received calcium supplementation for 3 years. The same group of researchers conducted a double-blind five-year RCT and found that calcium supplementation at 1,200 mg/day did not increase the mortality risk or the rate of hospital admissions due to atherosclerotic vascular disease (13). Another study found that the calcium coronary scores did not differ between women who underwent calcium and vitamin D supplementation for 7 years and a control group (72). Kim and cols. (73) also failed to observe an increased risk of calcification of the coronary arteries in patients with higher nutritional calcium intakes. Neither medicinal supplementation nor dietary calcium intake increased the risk of calcification in the coronary and carotid arteries or abdominal aorta of diabetic patients (26). Ivey and cols. (27) found that the intake of dairy products did not increase participants’ intima-media thickness. Additionally, yogurt intake was associated with a reduction in the thicknesses of these layers. Hyperhomocysteinemia (a marker of cardiovascular events in patients with atherosclerosis) is correlated with lower daily calcium intake (28), and not the reverse.

Calcium and blood pressure

The effect of calcium supplementation on blood pressure has also been evaluated (29,68,74-76). Wang and cols. (29) found a negative correlation between blood pressure and dietary calcium intake but found no correlation in a group that received supplementation. Pfeifer and cols. (68) found reductions in both systolic and diastolic blood pressures in patients receiving calcium (1,200 mg/day) and vitamin D (800 IU/day) supplementation. Another study examined 1,471 postmenopausal women and found a small decrease in diastolic blood pressure after 6 months of calcium supplementation that was not sustained after 30 months (74). The same author found no statistically significant differences between the blood pressures men who received calcium supplementation and men who received placebo treatment for 2 years (75). Another study also reported elevated systolic blood pressure related to calcium supplementation, although this finding was not clinically significant (76).

Calcium and diabetes mellitus

Studies have demonstrated beneficial or neutral effects of calcium dietary intake and medicinal supplementation on the development of diabetes (30,31,77,78). A meta-analysis involving 264,268 participants and 11,225 reported cases did not find a correlation between dietary calcium intake and diabetes (30). Tong and cols. (31) performed another meta-analysis and found an inverse correlation between the intake of dairy products and the development of diabetes. An analysis that assessed the role of medicines containing calcium in the risk of diabetes that was performed on the WHI study participants who received calcium and vitamin D supplementation for 7 years revealed no significant difference in newly diagnosed cases of diabetes compared with the control group (77). Calcium citrate and vitamin D supplementation for 3 years in patients with impaired fasting glucose has been found to result in attenuations of hyperglycemia and insulin resistance compared with placebo (78). Improvements in insulin sensitivity have also been reported in diabetic and hypertensive patients after 8 weeks of medicinal calcium supplementation compared with placebo (79).

Calcium and body weight

The effect of calcium supplementation on body weight seems uncertain. One study found neutral effects of calcium supplementation on weight (74). An analysis of five clinical trials involving 780 women reported a beneficial effect of calcium supplementation on body weight (80). Similarly, Shahar and cols. (32) reported a body weight reduction in a group with greater dietary calcium intake. Three systematic reviews have assessed the role of calcium supplementation on body weight. Onakpoya and cols. (81) found small but significant reductions in weight among overweight and obese individuals; however, the other two studies failed to confirm any correlation of dietary or calcium supplements with body weight (82,83).

Calcium and lipids

Reid and cols. (84) randomized 223 postmenopausal women to receive 1,000 mg/day of calcium citrate or placebo. These authors reported a 7% increase in high-density lipoprotein (HDL) levels at 12 months after the initiation of supplementation. Another study conducted by Reid reported no significant changes in lipids in men who received placebo or elemental calcium supplementation (600 to 1,200 mg/day) for 2 years (75). A decrease in triglyceride level following calcium supplementation has also been reported (76). In contrast, no significant change was observed in the serum lipids of 193 patients who were subjected to calcium supplementation (85).

Dietary calcium supplementation versus medicinal calcium supplementation

As previously described, the studies that have assessed the effects of supplementary calcium on cardiovascular mortality have produced contradictory results (6-24). The results related to the intake of calcium-rich foods (e.g., milk, cheese, and yogurt) have demonstrated reduced mortality due to CVD (6,7,24) and reduced risks of MI (15,24) and stroke (21,23,24). These studies have also demonstrated neutral or beneficial profiles for factors such as atherosclerosis (26-28), blood pressure (29), plasma glucose (30,31) and body weight (32).

Additionally, the risk of nephrolithiasis, which is known to be elevated in patients taking calcium supplements (57), is minimized in patients who ingest calcium through dietary sources (33) because dietary calcium binds to oxalate inside the digestive tract to form a poorly absorbed complex, which reduces hyperoxaluria (which is responsible for the formation of most kidney stones). This effect does not seem to occur with the use of calcium supplements (86). Low-calcium food intake also increases the risk of nephrolithiasis because it facilitates the intestinal absorption of oxalate and consequently increases its renal clearance (86). Negative calcium balance leads to PTH secretion, which increases urinary calcium by stimulating bone resorption and may thus be an additional factor that triggers nephrolithiasis in these patients (87,88).

The effectiveness of supplementation still depends on the compliance of patients, which has been described as low among users of calcium supplements. Additionally, adverse gastrointestinal effects may limit adherence and are less common with dietary calcium nutrients (18,47-50).

Another benefit of dietary rather than medicinal supplementation is the minimization of the transient hypercalcemia that has been described in patients taking calcium supplements (63) and has been suggested to be the hypothetical cause of increased the cardiovascular risk in these patients (3,9).

In conclusion, several studies have demonstrated the efficacies of calcium supplementation alone or in combination with vitamin D supplementation in the development and maintenance of bone mass, osteoporosis treatment and the reduction of the risk of fractures. The intake of nutrients rich in calcium is a priority because such intake has the same benefits as medicinal supplementation in terms of bone health and provides other additional important nutrients, such as proteins, while minimizing the risk of side effects (e.g., nephrolithiasis and gastrointestinal intolerance) and low adherence to drug treatment. Thus, supplementation should be restricted to individuals who are unable to achieve the recommended daily nutritional intake.

Some authors have evaluated the risk-benefit ratio of calcium supplementation and suggested a possible increase in cardiovascular risk, which contrasts with other studies that have described neutral or even protective effects regarding cardiovascular complications. These hypotheses have not been conclusively proven or disproven, and the different study designs and primary outcomes prevent us from reaching conclusions. Calcium supplementation has been demonstrated to be safe with in terms of atherosclerosis, blood pressure, diabetes, body weight and dyslipidemia, and these factors are known to be correlated with the risk of cardiovascular complications. However, studies that have assessed the cardiovascular risk associated with the nutritional intake of calcium-rich foods have proven the safety of this approach; therefore, nutritional calcium intake should be prioritized.

Prescribing calcium and vitamin D supplementation only to those individuals who will benefit from such treatment, promoting the intake of calcium-rich foods, restricting supplementation to people who do not achieve the recommended daily requirements, and avoiding excessive supplementation by following the suggested recommendations (i.e., a maximum of 1,500 mg/day of calcium) are all useful practices for osteoporosis prevention and treatment and do not seem to increase the risk of cardiovascular complications.

Further studies aimed at assessing the risk-benefit ratios of calcium supplementation in different populations are needed to define calcium’s true relationship with cardiovascular outcomes.


1. Aloia J, Bojadzievski T, Yusupov E, Shahzad G, Pollack S, Mikhail M, et al. The relative influence of calcium intake and vitamin D status on serum parathyroid hormone and bone turnover biomarkers in a double-blind, placebo-controlled parallel group, longitudinal factorial design. J Clin Endocrinol Metab. 2010;95(7):3216-24. [ Links ]

2. Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Inter Med. 2011;155(12):827-38. [ Links ]

3. Reid IR, Bolland MJ, Avenell A, Grey A. Cardiovascular effects of calcium supplementation. Osteoporos Int. 2011;22(6):1649-58. [ Links ]

4. Slinin Y, Blackwell T, Ishani A, Cummings SR, Ensrud KE; MORE Investigators. Serum calcium, phosphorus and cardiovascular events in post-menopausal women. Int J Cardiol. 2011;149(3):335-40. [ Links ]

5. Grandi NC, Brenner H, Hahmann H, Wüsten B, März W, Rothenbacher D, et al. 2012. Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart. 2012;98(12):926-33. [ Links ]

6. Van Hemelrijck M, Michaelsson K, Linseisen J, Rohrmann S. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One. 2013;8(4):e61037. [ Links ]

7. Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol. 1999;149(2):151-61. [ Links ]

8. Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115(7):846-54. [ Links ]

9. Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ. 2008;336(7638):262-6. [ Links ]

10. Pentti K, Tuppurainen MT, Honkanen R, Sandini L, Kröger H, Alhava E, et al. Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas. 2009;63(1):73-8. [ Links ]

11. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. [ Links ]

12. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women´s Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040. [ Links ]

13. Lewis JR, Calver J, Zhu K, Flicker L, Prince RL. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res. 2011;26(1):35-41. [ Links ]

14. Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab. 2012;97(2):614-22. [ Links ]

15. Li K, Kaaks R, Linseisen J, Rohrmann S. Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart. 2012;98(12):920-5. [ Links ]

16. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab. 2012;97(8):2670-81. [ Links ]

17. Langsetmo L, Berger C, Kreiger N, Kovacs CS, Hanley DA, Jamal AS, et al. Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab. 2013;98(7):3010-8. [ Links ]

18. Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, et al. Health risks and benefits from calcium and vitamin D supplementation: Women’s Health Initiative clinical trial and cohort study. Osteoporos Int. 2013;24(2):567-80. [ Links ]

19. Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality. JAMA Intern Med. 2013;173(8):639-46. [ Links ]

20. Paik JM, Curhan GC, Sun Q, Rexrode KM, Manson JE, Rimm EB, et al. Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int. 2014;25(8):2047-56. [ Links ]

21. Iso H, Stampfer MJ, Manson JE, Rexrode K, Hennekens CH, Colditz GA, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999;30(9):1772-9. [ Links ]

22. Larsson SC, Orsini N, Wolk A. Dietary calcium intake and risk of stroke: a dose-response meta-analysis. Am J Clin Nutr. 2013;97(5):951-7. [ Links ]

23. Levitan EB, Shikany JM, Ahmed A, Snetselaar LG, Martin LW, Curb JD, et al. Calcium, magnesium and potassium intake and mortality in women with heart failure: the Women’s Health Initiative. Br J Nutr. 2013;110(1):179-85. [ Links ]

24. Khan B, Nowson CA, Daly RM, English DR, Hodge AM, Giles GG, et al. Higher dietary calcium intakes are associated with reduced risks of fractures, cardiovascular events, and mortality: a prospective cohort study of older men and women. J Bone Miner Res. 2015;30(10):1758-66. [ Links ]

25. Verbrugge FH, Gielen E, Milisen K, Boonen S. Who should receive calcium and vitamin supplementation? Age Ageing. 2012;41(5):576-80. [ Links ]

26. Raffield LM, Agarwal S, Cox AJ, Hsu FC, Carr JJ, Freedman BI, et al. Cross-sectional analysis of calcium intake for associations with vascular calcification and mortality in individuals with type 2 diabetes from the Diabetes Heart Study. Am J Clin Nutr. 2014;100(4):1029-35. [ Links ]

27. Ivey KL, Lewis JR, Hodgson JM, Zhu K, Dhaliwal SS, Thompson PL, et al. Association between yogurt, milk, and cheese consumption and common carotid artery intima-media thickness and cardiovascular disease risk factors in elderly women. Am J Clin Nutr. 2011;94(1):234-9. [ Links ]

28. Tanaka S, Uenishi K, Yamazaki Y, Kuroda T, Shiraki M. Low calcium intake is associated with high plasma homocysteine levels in postmenopausal women. J Bone Miner Metab. 2014;32(3):317-23. [ Links ]

29. Wang L, Manson JE, Buring JE, Lee IM, Sesso HD. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008;51(4):1073-9. [ Links ]

30. Dong JY, Qin LQ. Dietary calcium intake and risk of type 2 diabetes: possible confounding by magnesium. Eur J Clin Nutr. 2012;66(3):408-10. [ Links ]

31. Tong X, Dong JY, Wu ZW, Li W, Qin LQ. Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies. Eur J Clin Nutr. 2011;65(9):1027-31. [ Links ]

32. Shahar DR, Schwarzfuchs D, Fraser D, Vardi H, Thiery J, Fiedler GM, et al. Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr. 2010;92(5):1017-22. [ Links ]

33. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126(7):497-504. [ Links ]

34. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al.; Women’s Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006;354(7):669-83. [ Links ]

35. Sanders KM, Nowson CA, Kotowicz MA, Briffa K, Devine A, Reid IR; Working group: Australian and New Zealand Bone and Mineral Society and Osteoporosis Australia. Calcium and bone health: position statment for the Australian and New Zealand Bone and Mineral Society, Osteoporosis Australia and the Endocrine Society of Australia. Med J Aust. 2009;190(6):316-20. [ Links ]

36. Devine A, Dick IM, Islam AF, Dhaliwal SS, Prince RL. Protein consumption is an important predictor of lower limb bone mass in elderly women. Am J Clin Nutr. 2005;81(6):1423-8. [ Links ]

37. Binkley N, Krueger D, Buehring B. What’s in a name revisited: should osteoporosis and sarcopenia be considered components of “dysmobility syndrome?”. Osteoporos Int. 2013;24(12):2955-9. [ Links ]

38. Papaioannou A, Santesso N, Morin SN, Feldman S, Adachi JD, Crilly R, et al.; Scientific Advisory Council of Osteoporosis Canada. Recommendations for preventing fracture in long-term care. CMAJ. 2015;187(15):1135-44, E450-61. [ Links ]

39. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377(9773):1276-87. [ Links ]

40. Heaney RP. The importance of calcium intake for lifelong skeletal health. Calcif Tissue Int. 2002;70(2):70-3. [ Links ]

41. Zhang ZQ, Ma XM, Huang ZW, Yang XG, Chen YM, Su YX. Effects of milk salt supplementation on bone mineral gain in pubertal Chinese adolescents: a 2-year randomized, double-blind, controlled, dose-response trial. Bone. 2014;65:69-76. [ Links ]

42. Kalkwarf HJ, Khoury JC, Lanphear BP. Milk intake during childhood and adolescence, adult bone density, and osteoporotic fractures in US women. Am J Clin Nutr. 2003;77(1):257-65. [ Links ]

43. Kim KM, Choi SH, Lim S, Moon JH, Kim JH, Kim SW, et al. Interactions between dietary calcium intake and bone mineral density or bone geometry in a low calcium intake population (KNHANES IV 2008-2010). J Clin Endocrinol Metab. 2014;99(7):2409-17. [ Links ]

44. Sahni S, Mangano KM, Tucker KT, Kiel DP, Casey VA, Hannan MT. Protective association of milk intake on the risk of hip fracture: results from the Framingham Original Cohort. J Bone Miner Res. 2014;29(8):1756-62. [ Links ]

45. Key TJ, Appleby PN, Spencer EA, Roddan AW, Neale RE, Allen NE. Calcium, diet and fracture risk: a prospective study of 1898 incident fractures among 34 696 British women and men. Public Health Nutr. 2007;10(11):1314-20. [ Links ]

46. Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, Burckhardt P, Li R, Spiegelman D, et al. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr. 2007;86(6):1780-90. [ Links ]

47. Shea B, Wells G, Cranney A, Zytaruk, Robinson V, Griffith L, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev. 2002;23(4):552-9. [ Links ]

48. Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005;365(9471):1621-8. [ Links ]

49. Tang BMP, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370(9588):657-66. [ Links ]

50. Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006;166(8):869-75. [ Links ]

51. Heaney RP, Magowan S, Zhou X, et al. Prevalence of low calcium intake in postmenopausal osteoporotic women: the need for supplementation. J Bone Miner Res. 2005;20(Suppl 1):S378. [ Links ]

52. Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA. Nutrient intakes related to osteoporotic fractures in men and women – The Brazilian Osteoporosis Study (BRAZOS). Nutr J. 2009;8:6. [ Links ]

53. Boonen S, Lips P, Boullon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2007;92(4):1415-23. [ Links ]

54. Nordin C, Need AG, Morris HA, O’Loughlin PD, Horowitz M. Effect of age on calcium absorption in postmenopausal women. Am J Clin Nutr. 2004;80(4):998-1002. [ Links ]

55. Binkley N, Novotny R, Krueger D, Kawahara T, Daida YG, Lensmeyer G, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007;92(6):2130-5. [ Links ]

56. Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014;99(11):4336-45. [ Links ]

57. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int. 2009;20(2):315-22. [ Links ]

58. Zhu K, Devine A, Dick IM, Wilson SG, Prince RL. Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a five-year randomized controlled trial. J Clin Endocrinol Metab. 2008;93(3):743-9. [ Links ]

59. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992;327(23):1637-42. [ Links ]

60. Winzenberg TM, Shaw KA, Fryer J, Jones G. Calcium supplementation for improving bone mineral density in children. Cochrane Database Syst Rev. 2006;(2):CD005119. [ Links ]

61. International Osteoporosis Foundation. 2014. Osteoporosis and musculoskeletal disorders – Osteoporosis – Prevention – Calcium – See our comprehensive of calcium-rich foods. Disponível em: [ Links ]

62. Body JJ, Bergmann P, Boonen S, Devogelaer JP, Gielen E, Goemaere S, et al. Extra-skeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. Osteoporos Int. 2012;23 Suppl 1:S1-23. [ Links ]

63. Deroisy R, Zartarian M, Meurmans L, Nelissenne N, Micheletti MC, Albert A, et al. Acute changes in serum calcium and parathyroid hormone circulate levels induced by the oral intake of five currently available calcium salts in healthy male volunteers. Clin Rheumatol. 1997;16(3):249-53. [ Links ]

64. Burt MG, Mangelsdorf BL, Srivastava D, Petersons CJ. Acute effect of calcium citrate on serum calcium and cardiovascular function. J Bone Miner Res. 2013;28(2):412-8. [ Links ]

65. Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2009;205(1):255-60. [ Links ]

66. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81. [ Links ]

67. Paik JM, Curhan GC, Taylor EM. Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study. BMJ. 2014;345:e6390. [ Links ]

68. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86(4):1633-7. [ Links ]

69. Jorde R, Szumlas K, Haug E, Sundsfjord J. The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake. Eur J Nutr. 2002;41(6):258-63. [ Links ]

70. Rubin MR, Rundek T, McMahon DJ, Lee HS, Sacco RL, Silverberg SJ. Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study. Atherosclerosis. Atherosclerosis. 2007;194(2):426-32. [ Links ]

71. Lewis JR, Zhu K, Thompson PL, Prince RL. The effects of 3 years of calcium supplementation on common carotid artery intimal medial thickness and carotid atherosclerosis in older women: an ancillary study of the CAIFOS randomized controlled trial. J Bone Miner Res. 2014;29:534-41. [ Links ]

72. Manson JE, Allison MA, Carr JJ, Langer RD, Cochrane BB, Hendrix SL, et.; Women’s Health Initiative and Women’s Health Initiative-Coronary Artery Calcium Study Investigators. Calcium/vitamin D supplementation and coronary artery calcification in the Women´s Health Initiative. Menopause. 2010;17(4):683-91. [ Links ]

73. Kim JH, Yoon JW, Kim KW, Lee W, Cho S-H, Shin CS. Increased dietary calcium intake is not associated with coronary artery calcification. Int J Cardiol. 2012;157(3):429-31. [ Links ]

74. Reid IR, Horne A, Mason B, Ames R, Bava U, Gamble GD. Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial. J Clin Endocrinol Metab. 2005;90(7):3824-9. [ Links ]

75. Reid IR, Ames R, Mason B, Bolland MJ, Bacon CJ, Reid HE, et al. Effects of calcium supplementation on lipids, blood pressure and body composition in healthy older men: a randomized controlled trial. Am J Clin Nutr. 2010;91(1):131-9. [ Links ]

76. Chai W, Cooney RV, Franke AA, Bostick RM. Effects of calcium and vitamin D supplementation on blood pressure and serum lipids and carotenoids: a randomized, double-blind, placebo-controlled clinical trial. Ann Epidemiol. 2013;23(9):564-70. [ Links ]

77. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B, et al. 2008. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women’s Health Initiative. Diabetes Care. 2008;31(4):701-7. [ Links ]

78. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effect of calcium and vitamin D supplementation on blood glucose and markers of infammation in nondiabetic adults. Diabetes Care. 2007;30(4):980-6. [ Links ]

79. Pikilidou MI, Lasaridis AN, Sarafidis PA, Befani CD, Koliakos GG, Tziolas IM, et al. Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with Type 2 diabetes. Diabet Med. 2009;26(3):211-9. [ Links ]

80. Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, et al. Calcium intake and body weight. J Clin Endocrinol Metab. 2000;85(12):4635-8. [ Links ]

81. Onakpoya IJ, Perry R, Zhang J, Ernst E. Efficacy of calcium supplementation for management of overweight and obesity: systematic review of randomized clinical trials. Nutr Rev. 2011;69(6):335-43. [ Links ]

82. Lanou AJ, Bernard ND. Dairy and weight loss hypothesis: an evaluation of the clinical trials. Nutr Rev. 2008;66(5):272-9. [ Links ]

83. Trowman R, Dumville JC, Hahn S, Torgerson DJ. A systematic review of the effects of calcium supplementation on body weight. Br J Nutr. 2006;95(6):1033-8. [ Links ]

84. Reid IR, Mason B, Horne A, Ames R, Clearwater J, Bava U, et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med. 2002;112(5):343-7. [ Links ]

85. Bostick RM, Fosdick L, Grambsch P, Gross M, Louis TA. Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled clinical trial. Arch Fam Med. 2000;9(1):31-8. [ Links ]

86. Bihl G, Meyers A. Recurrent renal stones disease-advances in pathogenesis and clinical management. Lancet. 2001;358(9282): 651-6. [ Links ]

87. Curhan GC, Willett WC, Spiezer FE, Stampfer MJ. Twenty-four hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59(6):2290-8. [ Links ]

88. Heilberg IP, Goldfarb DS. Optimal nutrition for kidney stone disease. Adv Chronic Kidney Dis. 2013;20(2):165-74. [ Links ]

Received: January 22, 2016; Accepted: March 10, 2016

Correspondence to: Guilherme Alcantara Cunha Lima. Rua Barão da Lagoa Dourada, 340/1302. 28035-212 – Campos dos Goytacazes, RJ, Brasil.

Disclosure: no potential conflict of interest relevant to this article was reported.

Creative Commons License  This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.